Recently, gene expression profiling has identified molecular subtypes that classify invasive breast cancers into distinct categories that vary in their clinical behavior and response to treatment. These subtypes highlight the many possible biologically and clinically distinct types of breast cancer. With such heterogeneity within breast cancer, we might expect that risk factors influence specific subtypes of breast cancer through different etiologic pathways. Mammographic density (MD), the proportion of the white or dense regions on a mammogram, has been shown to be one of the strongest and most consistent risk factors for breast cancer. We propose a large collaboration of four established cohort studies [Nurses'Health Study (I and II) Blood Subcohorts, Mayo Mammography Health Study and San Francisco Mammography Registry/UCSF SPORE] with similar methods for ascertaining risk factors, MD, breast cancer and breast cancer subtype information, to examine the association of MD with subtypes of invasive breast cancer. Specifically, we propose Aim 1) To ascertain and combine clinical risk factor, MD and breast cancer information to create a large nested case-control study of ~3300 women with invasive breast cancer and ~5700 matched controls, Aim 2) To characterize breast cancer subtypes for all invasive breast cancers using information from pathology reports, cancer registries and pathologic review. We propose to classify cancers according to hormone receptors (estrogen (ER) and progesterone (PR)), human epidermal growth factor-2 (HER2) expression, tumor size, nodal involvement, histologic subtype and grade. Also, using both clinically available information and results from immunohistochemistry and FISH analyses, we will classify cancers into the 'intrinsic'molecular subtypes defined as Luminal A, Luminal B, Basal-like, HER2-expressing and Unclassified.
Aim 3) To evaluate the association of MD with each of the histologic and molecular breast cancer subtypes defined in Aim 2, and Aim 4) To combine MD and clinical breast cancer risk factor information to develop a risk prediction model for breast cancer and the specific breast cancer molecular subtypes. Our secondary aim will examine associations of novel parenchyma features of digitized mammogram films with breast cancer and histologic and molecular breast cancer subtypes. Successful completion of this protocol will 1) address the question whether MD is associated with breast cancer subtypes, 2) result in a new risk prediction model for breast cancer and molecular subtypes, and 3) establish a large, collaborative nested-case control study with risk factors, MD, and well-annotated breast cancers that can be used for future studies. Identifying whether MD is associated with specific subtypes of breast cancer may result in more targeted prevention and surveillance strategies for women with high MD. Also, risk models for the molecular subtypes incorporating MD and parenchyma measures will likely be more informative than those treating breast cancer as one disease.

Public Health Relevance

Breast cancer is a heterogeneous disease with respect to etiology and prognosis. By studying risk factors for well-defined breast cancer subtypes, we will gain insight into etiologic pathways for these subtypes as well as better inform a woman's breast cancer risk and allow for targeted screening and prevention strategies. We will combine four large nested case-control studies to examine the association of one of the strongest and potentially modifiable risk factors, MD, with breast cancer molecular and histologic subtypes and develop a risk model for breast cancer and the molecular subtypes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA140286-05
Application #
8607513
Study Section
Special Emphasis Panel (ZRG1-PSE-B (03))
Program Officer
Shelburne, Nonniekaye F
Project Start
2010-04-01
Project End
2015-01-31
Budget Start
2014-02-01
Budget End
2015-01-31
Support Year
5
Fiscal Year
2014
Total Cost
$296,585
Indirect Cost
$64,205
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Nielsen, Mads; Vachon, Celine M; Scott, Christopher G et al. (2014) Mammographic texture resemblance generalizes as an independent risk factor for breast cancer. Breast Cancer Res 16:R37
Fowler, Erin E E; Vachon, Celine M; Scott, Christopher G et al. (2014) Automated Percentage of Breast Density Measurements for Full-field Digital Mammography Applications. Acad Radiol 21:958-70
Pettersson, Andreas; Graff, Rebecca E; Ursin, Giske et al. (2014) Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 106:
Reese, Sarah E; Archer, Kellie J; Therneau, Terry M et al. (2013) A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis. Bioinformatics 29:2877-83
Tice, Jeffrey A; O'Meara, Ellen S; Weaver, Donald L et al. (2013) Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst 105:1043-9
Vachon, Celine M; Fowler, Erin Ee; Tiffenberg, Gail et al. (2013) Comparison of percent density from raw and processed full-field digital mammography data. Breast Cancer Res 15:R1
Bertrand, Kimberly A; Tamimi, Rulla M; Scott, Christopher G et al. (2013) Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res 15:R104
Vachon, Celine M; Suman, Vera J; Brandt, Kathleen R et al. (2013) Mammographic breast density response to aromatase inhibition. Clin Cancer Res 19:2144-53
Ghosh, Karthik; Brandt, Kathleen R; Reynolds, Carol et al. (2012) Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat 131:267-75
Yaghjyan, Lusine; Colditz, Graham A; Collins, Laura C et al. (2011) Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 103:1179-89